题名

非侵襲性影像檢查對於肝纖維化的診斷與影響

DOI

10.6666/ClinMed.201910_84(4).0113

作者

李承翰;許朝偉

关键词

肝纖維化(liver fibrosis) ; 纖維化掃描(fibroscan) ; 彈性造影(elastography)

期刊名称

臨床醫學月刊

卷期/出版年月

84卷4期(2019 / 10 / 25)

页次

683 - 691

内容语文

繁體中文

中文摘要

肝纖維化程度的評估,對於慢性肝炎的診療是非常重要的。造成肝纖維化最常見的原因有:慢性B型肝炎、慢性C型肝炎、酒精性肝炎甚至脂肪肝。肝臟纖維化主要是由於肝組織的破壞,接著由疤痕組織(scar tissue)取代而形成。肝生檢是評估肝纖維化的黃金準則,然其侵襲性和取樣誤差一直是存在的問題,隨著影像檢查技術的進步,用以探測肝纖維化的方法也隨之增加,包含:傳統超音波、顯影劑超音波(contrast-enhanced ultrasound,CEUS)、電腦斷層、核磁共振影像,此外更有肝臟彈性造影檢查(liver elastography examinations),是利用原有的超音波或核磁共振影像為基底,專門針對肝纖維化的新一代檢查,其原理跟檢查的方式將回在本文中介紹,隨著各種非侵襲性的檢查正在逐漸發展成熟並且投入臨床應用,希望能夠帶給慢性肝炎患者更多元診療的選擇。

主题分类 醫藥衛生 > 基礎醫學
醫藥衛生 > 社會醫學
参考文献
  1. Afzal, S,Masroor, I,Beg, M(2013).Evaluation of chronic liver disease: does ultrasound scoring criteria help?.Int J Chronic Dis,2013,1-5.
  2. Choong, CC,Venkatesh, SK,Siew, EP(2012).Accuracy of routine clinical ultrasound for staging of liver fibrosis.J Clin Imaging Sci,2,58.
  3. European Association for the Study of the Liver(2015).EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.J Hepatol,63,237-264.
  4. Friedrich-Rust, M,Nierhoff, J,Lupsor, M(2012).Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis.J Viral Hepat,19,e212-e219.
  5. Grant, A,Neuberger, J(1999).Guidelines on the use of liver biopsy in clinical practice.Gut,45,IV1-IV11.
  6. Kudo, M,Zheng, RQ,Kim, SR(2008).Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study.Intervirology,51,17-26.
  7. Nierhoff, J,Chávez, Ortiz, AA,Herrmann, E(2013).The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis.Eur Radiol,23,3040-3053.
  8. Rockey, DC,Caldwell, SH,Goodman, ZD(2009).AASLD Position paper: liver biopsy.Hepatology,49,1017-1044.
  9. Seeff, LB,Everson, GT,Morgan, TR(2010).Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.Clin Gastroenterol Hepatol,8,877-883.
  10. Xu, R,Zhang, Z,Wang, FS(2012).Liver fifibrosis: mechanisms of immune-mediated liver injury.Cell Mol Immunol,9,296-301.